Phase 2Not yet recruiting
Combination Therapy for Alcohol Use Disorder
Preliminary Safety and Efficacy of Semaglutide and Naltrexone Combination Therapy for Alcohol Use Disorder
- Sponsor
- Johns Hopkins University (Academic or other)
- Enrolment
- 45 planned
- Conditions
- Alcohol Use Disorder
- Interventions
- Placebo; Glucagon-Like Peptide-1 Agonist (GLP-1); Naltrexone (oral tablets)
- Ages
- adults, older adults
- Registry
- NCT07249554
From the registry
This human laboratory study will collect preliminary safety and efficacy data from a sample of participants enrolled in a 4-week in-patient treatment program for alcohol use disorder.
Primary outcomes
- Participant-reported Adverse Events